Definitive Net Income From Continuing Ops from 2010 to 2026
| DH Stock | USD 1.96 0.09 4.39% |
Net Loss | First Reported 2020-09-30 | Previous Quarter -9.3 M | Current Value -17.8 M | Quarterly Volatility 89.2 M |
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.5 M, Interest Expense of 16.3 M or Selling General Administrative of 39.8 M, as well as many indicators such as Price To Sales Ratio of 2.08, Dividend Yield of 0.0051 or PTB Ratio of 1.18. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
Definitive | Net Income From Continuing Ops | Build AI portfolio with Definitive Stock |
The Net Income From Continuing Ops trend for Definitive Healthcare Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Definitive Healthcare is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Definitive Healthcare's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Definitive Healthcare Corp over the last few years. It is Definitive Healthcare's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Definitive Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (149,654,514) | |
| Coefficient Of Variation | (130.82) | |
| Mean Deviation | 152,855,256 | |
| Median | (51,157,000) | |
| Standard Deviation | 195,773,218 | |
| Sample Variance | 38327.2T | |
| Range | 569.2M | |
| R-Value | (0.71) | |
| Mean Square Error | 20212.6T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | (27,566,560) | |
| Total Sum of Squares | 613234.4T |
Definitive Net Income From Continuing Ops History
About Definitive Healthcare Financial Statements
Investors use fundamental indicators, such as Definitive Healthcare's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | -532.3 M | -505.7 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Definitive Healthcare Correlation against competitors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.62) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.